Health CarePharmaceuticals & Biotechnology
  • Price (ILA)10,130.00
  • Today's Change-200.00 / -1.94%
  • Shares traded259.52k
  • 1 Year change-48.37%
  • Beta0.9965
Data delayed at least 20 minutes, as of May 28 2017 14:24 BST.
More ▼

Key statistics

On Sunday, Teva Pharmaceutical Industries Ltd (TEVA:TLV) closed at 10,130.00, 0.70% above its 52-week low of 10,060.00, set on May 24, 2017.
52-week range
10,060.00May 24 201721,770.00Jul 13 2016
Markit short selling activity
Previous close10,330.00
Average volume584.83k
Shares outstanding1.01bn
Free float1.01bn
P/E (TTM)272.98
Market cap104.58bn ILS
EPS (TTM)0.3777 ILS
Annual div (ADY)510.95 ILA
Annual div yield (ADY)4.95%
Div ex-dateMar 02 2017
Div pay-dateMar 20 2017
Next div ex-dateJun 05 2017
Next div pay-dateJun 22 2017
Data delayed at least 20 minutes, as of May 28 2017 14:24 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.